Sign in

CIK 0001790340 · <br>Emerging growth company

Immuneering Corp

Sign in to watch
Ticker
IMRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
617-500-8080
Business address
245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 43 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2024-05-21 Morales Mallory Chief Accounting Officer Grant or award · Stock Option +23,850 23,850
2024-05-21 Morales Mallory Chief Accounting Officer Returned to the company · Stock Option −5,000 0
2024-05-21 Morales Mallory Chief Accounting Officer Grant or award · Stock Option +5,000 5,000
2024-05-21 Morales Mallory Chief Accounting Officer Returned to the company · Stock Option −15,000 0
2024-05-21 Morales Mallory Chief Accounting Officer Grant or award · Stock Option +15,000 15,000
2024-05-21 Morales Mallory Chief Accounting Officer Returned to the company · Stock Option −60,500 0
2024-05-21 Morales Mallory Chief Accounting Officer Grant or award · Stock Option +60,500 60,500
2024-05-21 Morales Mallory Chief Accounting Officer Returned to the company · Stock Option −72,000 0
2024-05-21 Morales Mallory Chief Accounting Officer Grant or award · Stock Option +72,000 72,000
2024-05-21 Brakewood Harold Eugene Chief Business Officer Returned to the company · Stock Option −165,000 0
2024-05-21 Brakewood Harold Eugene Chief Business Officer Grant or award · Stock Option +165,000 165,000
2024-05-21 Brakewood Harold Eugene Chief Business Officer Returned to the company · Stock Option −60,500 0
2024-05-21 Brakewood Harold Eugene Chief Business Officer Grant or award · Stock Option +60,500 60,500
2024-05-21 Neufeld Leah R CHIEF PEOPLE OFFICER Returned to the company · Stock Option −88,600 0
2024-05-21 Neufeld Leah R CHIEF PEOPLE OFFICER Grant or award · Stock Option +88,600 88,600
2024-05-21 Neufeld Leah R CHIEF PEOPLE OFFICER Returned to the company · Stock Option −105,000 0
2024-05-21 Neufeld Leah R CHIEF PEOPLE OFFICER Grant or award · Stock Option +105,000 105,000
2024-05-21 Neufeld Leah R CHIEF PEOPLE OFFICER Returned to the company · Stock Option −60,500 0
2024-05-21 Neufeld Leah R CHIEF PEOPLE OFFICER Grant or award · Stock Option +60,500 60,500
2024-04-01 Cormorant Asset Management, LP 10% owner Sale −100 $3.07 $307 3,295,173

Page 5 of 8 · 150 trades